OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Showing 16 citing articles:
A bouncing computational model of particle-mucus interaction for predictive deposition maps in the airways
Silvia Ceccacci, Hadrien Calmet, Abel Gargallo-Peiró, et al.
Journal of Aerosol Science (2025), pp. 106536-106536
Open Access
Silvia Ceccacci, Hadrien Calmet, Abel Gargallo-Peiró, et al.
Journal of Aerosol Science (2025), pp. 106536-106536
Open Access
SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner
Moe Kobayashi, Nobuyuki Kobayashi, Koichiro Deguchi, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Moe Kobayashi, Nobuyuki Kobayashi, Koichiro Deguchi, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice
Yihua Jiang, Lingjin Sun, Nan Qiao, et al.
Virologica Sinica (2024) Vol. 39, Iss. 4, pp. 675-684
Open Access | Times Cited: 2
Yihua Jiang, Lingjin Sun, Nan Qiao, et al.
Virologica Sinica (2024) Vol. 39, Iss. 4, pp. 675-684
Open Access | Times Cited: 2
Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models
Elena P. Mazunina, Vladimir А. Gushchin, Evgeniia N. Bykonia, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1206-1206
Open Access | Times Cited: 2
Elena P. Mazunina, Vladimir А. Gushchin, Evgeniia N. Bykonia, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1206-1206
Open Access | Times Cited: 2
Beta Spike-Presenting SARS-CoV-2 Virus-Like Particle Vaccine Confers Broad Protection against Other VOCs in Mice
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
(2024)
Open Access | Times Cited: 1
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
(2024)
Open Access | Times Cited: 1
Lung-resident CD3−NK1.1+CD69+CD103+ Cells Play an Important Role in Bacillus Calmette–Guérin Vaccine–Induced Protective Immunity against Mycobacterium tuberculosis Infection
Olamipejo Durojaye, Abhinav Vankayalapati, Padmaja Paidipally, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 5, pp. 669-677
Closed Access
Olamipejo Durojaye, Abhinav Vankayalapati, Padmaja Paidipally, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 5, pp. 669-677
Closed Access
Nanoparticle-Mediated Mucosal Vaccination: Harnessing Nucleic Acids for Immune Enhancement
Wajid Hussain, Sadia Chaman, Hafiza Nazia Koser, et al.
Current Microbiology (2024) Vol. 81, Iss. 9
Closed Access
Wajid Hussain, Sadia Chaman, Hafiza Nazia Koser, et al.
Current Microbiology (2024) Vol. 81, Iss. 9
Closed Access
Preclinical evaluation of a cross-protective ß-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
Joseph Torresi, Linda Earnest, Daniel Fernandez‐Ruiz, et al.
Research Square (Research Square) (2024)
Open Access
Joseph Torresi, Linda Earnest, Daniel Fernandez‐Ruiz, et al.
Research Square (Research Square) (2024)
Open Access
Beta Spike-Presenting SARS-CoV-2 Virus-like Particle Vaccine Confers Broad Protection against Other VOCs in Mice
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1007-1007
Open Access
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1007-1007
Open Access
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Monrat Chulanetra, Primana Punnakitikashem, Kodchakorn Mahasongkram, et al.
Research Square (Research Square) (2024)
Closed Access
Monrat Chulanetra, Primana Punnakitikashem, Kodchakorn Mahasongkram, et al.
Research Square (Research Square) (2024)
Closed Access
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights
Sophie O’Reilly, Joanne Byrne, Eoin R. Feeney, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1089-1089
Open Access
Sophie O’Reilly, Joanne Byrne, Eoin R. Feeney, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1089-1089
Open Access
Linking COVID-19 and cancer: Underlying mechanism
Sourabh Tyagi, Nipanshi Tyagi, A. K. Singh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167563-167563
Closed Access
Sourabh Tyagi, Nipanshi Tyagi, A. K. Singh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167563-167563
Closed Access
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Monrat Chulanetra, Primana Punnakitikashem, Kodchakorn Mahasongkram, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Monrat Chulanetra, Primana Punnakitikashem, Kodchakorn Mahasongkram, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters
Ekaterina Stepanova, Victoria Matyushenko, Daria A Mezhenskaia, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1300-1300
Open Access
Ekaterina Stepanova, Victoria Matyushenko, Daria A Mezhenskaia, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1300-1300
Open Access
A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV
Nan Gao, Tianhan Yang, Lanlan Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Nan Gao, Tianhan Yang, Lanlan Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
